跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rotarix Oral Suspension (Oral Applicator) - HSA Drug Approval Details
Approvals
/
HSA
/
Rotarix Oral Suspension (Oral Applicator)
Approved
STANDARD
Rotarix Oral Suspension (Oral Applicator)
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
a2f250fd4957b670
Company
Unknown
Type
Standard
Approval Details
Approval Id
a2f250fd4957b670
Drug Name
Rotarix Oral Suspension (Oral Applicator)
Active Ingredients
HUMAN ROTAVIRUS, LIVE, ATTENUATED, RIX 4414 STRAIN
Not less than 10⁶ CCID₅₀/dose (1.5 ml)
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
a2f250fd4957b670
Type
Standard
Back to HSA Approvals